The Impact of the SCN9A Gene Polymorphism on Postoperative Pain

NCT02496455 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-11-21

No results posted yet for this study

Summary

The purpose of this study to determine the association between postoperative pain after cesarean section and several single nucleotide polymorphisms in SCN9A sodium channels gene.

Conditions

  • Pain, Postoperative
  • Pregnancy

Interventions

PROCEDURE

cesarean section

Women in 36 to 40 weeks of pregnancy undergoing cesarean section by Pfannenstiel technique

DRUG

Opioid Tramadol

Tramadol will be administered via patient controlled analgesia (PCA) pump in the postoperative period

Sponsors & Collaborators

  • Tokat Gaziosmanpasa University

    lead OTHER

Principal Investigators

  • Tugba Karaman, M.D. · Gaziosmanpasa University Medical School

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-08-31
Primary Completion
2017-05-31
Completion
2017-11-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02496455 on ClinicalTrials.gov